The Global In Vitro Toxicology Testing Market is accounted for $14.13 billion in 2016 and is expected to reach $37.27 billion by 2023 growing at a CAGR of 14.8%

LONDON, March 20, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/4300267



By technology, cell culture technologies segment is anticipated to occupy the largest share. During the process of inhaling the human lungs may get exposed to toxic particles from the air which damages the respiratory system. With the help of cell culture technologies one can identify the risk associated with the toxic particles and the risk can balanced against other benefits.

On the basis of region, North America is forecasted to occupy largest share due to the presence of large players in this region that offers In Vitro technology. Also, stringent regulations regarding the animal usage in toxicity analysis contribute towards high requirement of in-vitro tests in this region.

Some of the key players in global In Vitro Toxicology Testing market include Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Covance, Inc. (A Part of Laboratory Corporation of America Holdings), Eurofins Scientific Se, GE Healthcare, Thermo Fisher Scientific, Inc, SGS S.A., Qiagen N.V., Gentronix Limited, MB Research Laboratories, Promega Corporation, Merck KGaA, Cyprotex PLC (A Subsidiary of Evotec Ag), Ascendance Biotechnology, Inc. and Catalent, Inc.

Methods Covered:
• Biochemical Assays
• Cellular Assays
• In Silico Method
• EX Vivo Models
• Other Methods

Product and Services Covered:
• Services
• Assays
• Reagents & Labware

Technologies Covered:
• High-Throughput Technologies
• Cell Culture Technologies
• Molecular Imaging Technologies
• OMICS technology

Toxicity Endpoints and Tests Covered:
• Systemic Toxicity
• Organ Toxicity
• Ocular Toxicity
• Phototoxicity Testing
• Genotoxicity Testing
• Dermal Toxicity
• Cytotoxicity Testing
• Neurotoxicity
• Carcinogenicity
• Other Toxicity Endpoints & Tests

End Users Covered:
• Cosmetics and Household Products Industry
• Diagnostics
• Pharmaceutical and Biopharmaceutical Industry
• Chemical Industry
• Food Industry

Types Covered:
• ADME (Absorption, Distribution, Metabolism, and Excretion)
• Dose
• Toxic Substances

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Download the full report: https://www.reportbuyer.com/product/4300267

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com  
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com  

View original content:http://www.prnewswire.com/news-releases/the-global-in-vitro-toxicology-testing-market-is-accounted-for-1413-billion-in-2016-and-is-expected-to-reach-3727-billion-by-2023-growing-at-a-cagr-of-148-300616970.html

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com